Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
ProQR (PRQR)
NASDAQ:PRQR
ProQR (PRQR) Stock Price & Analysis
852 Followers
PRQR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.53 - $3.85
Previous Close$2.52
Volume2.15M
Average Volume (3M)1.20M
Market Cap
$148.28M
Enterprise Value$94.52M
Total Cash (Recent Filing)€100.43M
Total Debt (Recent Filing)€22.22M
Price to Earnings (P/E)-2.3
Beta0.62
Next Earnings
May 10, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.08
Shares Outstanding71,434,624
10 Day Avg. Volume1,213,224
30 Day Avg. Volume1,199,013
Standard Deviation0.39
R-Squared0.00025
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)3.84
Price to Sales (P/S)81.15
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-4.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4.67Price Target Upside124.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
ProQR News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PRQR FAQ
What was ProQR’s price range in the past 12 months?
ProQR lowest stock price was $0.53 and its highest was $3.85 in the past 12 months.
What is ProQR’s market cap?
Currently, no data Available
When is ProQR’s upcoming earnings report date?
ProQR’s upcoming earnings report date is May 10, 2023 which is in 41 days.
How were ProQR’s earnings last quarter?
Currently, no data Available
Is ProQR overvalued?
According to Wall Street analysts ProQR’s price is currently Undervalued.
Does ProQR pay dividends?
ProQR does not currently pay dividends.
What is ProQR’s EPS estimate?
ProQR’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ProQR have?
ProQR has 71,290,800 shares outstanding.
What happened to ProQR’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ProQR?
Among the largest hedge funds holding ProQR’s share is Gilder Gagnon Howe & Co LLC.. It holds ProQR’s shares valued at 359K.
---
ProQR Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.67 (124.52% Upside)
$4.67 (124.52% Upside)
Hedge Fund Trend
Decreased
By 26.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.0%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
159.25%
12-Months-Change
Fundamentals
Return on Equity
-72.83%
Trailing 12-Months
Asset Growth
-47.32%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
ProQR
ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.
---
Top 5 ETFs holding PRQR
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold PRQR. The ETFs are listed according to market value of PRQR within the ETF
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---